BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 19277429)

  • 1. Duration of anticoagulant treatment and recurrence of venous thromboembolism in patients with and without thrombophilic abnormalities.
    Taliani MR; Becattini C; Agnelli G; Prandoni P; Moia M; Bazzan M; Salvi R; Ageno W; Guazzaloca G; Imberti D; Silingardi M; Poggio R;
    Thromb Haemost; 2009 Mar; 101(3):596-8. PubMed ID: 19277429
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
    Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
    Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The problem of risk assessment and prophylaxis of venous thromboembolism in pregnancy.
    Krafft A
    Thromb Haemost; 2007 Dec; 98(6):1155-6. PubMed ID: 18064306
    [No Abstract]   [Full Text] [Related]  

  • 4. Duration of anticoagulant therapy for patients with venous thromboembolism.
    Garcia D
    Thromb Res; 2008; 123 Suppl 1():S62-4. PubMed ID: 18823648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism: risk factors for recurrence.
    Zhu T; Martinez I; Emmerich J
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombophilic states: their relevance in prevention and treatment of venous thromboembolism].
    Poul H; Kessler P
    Vnitr Lek; 2009 Mar; 55(3):242-52. PubMed ID: 19378855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
    Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
    Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study.
    Dargaud Y; Rugeri L; Vergnes MC; Arnuti B; Miranda P; Negrier C; Bestion A; Desmurs-Clavel H; Ninet J; Gaucherand P; Rudigoz RC; Berland M; Champion F; Trzeciak MC
    Br J Haematol; 2009 Jun; 145(6):825-35. PubMed ID: 19388925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant therapy and thromboprophylaxis in patients with thrombophilia.
    Weintraub AY; Sheiner E
    Arch Gynecol Obstet; 2007 Dec; 276(6):567-71. PubMed ID: 17828548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fondaparinux for prevention of venous thromboembolism in high-risk trauma patients: a pilot study.
    Lu JP; Knudson MM; Bir N; Kallet R; Atkinson K
    J Am Coll Surg; 2009 Nov; 209(5):589-94. PubMed ID: 19854398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary prevention of venous thromboembolism].
    Bauersachs RM
    Dtsch Med Wochenschr; 2012 Oct; 137(40):1994-7. PubMed ID: 23023608
    [No Abstract]   [Full Text] [Related]  

  • 12. The 8(th) American College of Chest Physicians Guidelines - a perspective on venous thromboembolism guidelines.
    Squizzato A; Ageno W
    Thromb Haemost; 2009 Jan; 101(1):31-5. PubMed ID: 19132186
    [No Abstract]   [Full Text] [Related]  

  • 13. Duration of anticoagulant therapy after first episode of venous thrombosis in patients with inherited thrombophilia.
    Hirsh J; Kearon C; Ginsberg J
    Arch Intern Med; 1997 Oct; 157(19):2174-7. PubMed ID: 9342993
    [No Abstract]   [Full Text] [Related]  

  • 14. Perioperative anticoagulant management.
    Grant PJ; Brotman DJ; Jaffer AK
    Med Clin North Am; 2009 Sep; 93(5):1105-21. PubMed ID: 19665623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of thrombophilia testing in pregnant women with thrombosis: fact or fiction?
    Scifres CM; Macones GA
    Am J Obstet Gynecol; 2008 Oct; 199(4):344.e1-7. PubMed ID: 18572147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels.
    Folkeringa N; Coppens M; Veeger NJ; Bom VJ; Middeldorp S; Hamulyak K; Prins MH; Büller HR; van der Meer J
    Thromb Haemost; 2008 Jul; 100(1):38-44. PubMed ID: 18612536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent venous thromboembolism: quite harmless after all?
    Konstantinides SV
    Thromb Haemost; 2008 Apr; 99(4):655-6. PubMed ID: 18392321
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticoagulation quality and the risk of recurrence of venous thromboembolism.
    Poli D; Antonucci E; Ciuti G; Abbate R; Prisco D
    Thromb Haemost; 2007 Nov; 98(5):1148-50. PubMed ID: 18000626
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticoagulants for thrombosis prophylaxis following surgery: a continuing saga.
    Caprini JA
    Thromb Haemost; 2008 Jun; 99(6):993-4. PubMed ID: 18521498
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombophilia and gestational VTE.
    Simioni P
    Thromb Res; 2009; 123 Suppl 2():S41-4. PubMed ID: 19217475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.